DK1408038T3 - Imidazole derivatives and their use as peripherally selective inhibitors dopamine beta-hydroxylase - Google Patents
Imidazole derivatives and their use as peripherally selective inhibitors dopamine beta-hydroxylaseInfo
- Publication number
- DK1408038T3 DK1408038T3 DK03256420T DK03256420T DK1408038T3 DK 1408038 T3 DK1408038 T3 DK 1408038T3 DK 03256420 T DK03256420 T DK 03256420T DK 03256420 T DK03256420 T DK 03256420T DK 1408038 T3 DK1408038 T3 DK 1408038T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydroxylase
- selective inhibitors
- imidazole derivatives
- dopamine beta
- peripherally selective
- Prior art date
Links
- 108010015720 Dopamine beta-Hydroxylase Proteins 0.000 title 1
- 102100033156 Dopamine beta-hydroxylase Human genes 0.000 title 1
- 229940124639 Selective inhibitor Drugs 0.000 title 1
- 150000002460 imidazoles Chemical class 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0223719A GB2393958A (en) | 2002-10-11 | 2002-10-11 | Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase |
| GB0224306A GB2394223B (en) | 2002-10-11 | 2002-10-18 | Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1408038T3 true DK1408038T3 (en) | 2008-11-24 |
Family
ID=9945777
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07076125.9T DK1908760T3 (en) | 2002-10-11 | 2003-10-10 | Chromatic and thiochroman-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine beta-hydroxylase and methods for their preparation |
| DK03256420T DK1408038T3 (en) | 2002-10-11 | 2003-10-10 | Imidazole derivatives and their use as peripherally selective inhibitors dopamine beta-hydroxylase |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07076125.9T DK1908760T3 (en) | 2002-10-11 | 2003-10-10 | Chromatic and thiochroman-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine beta-hydroxylase and methods for their preparation |
Country Status (11)
| Country | Link |
|---|---|
| KR (1) | KR101350741B1 (en) |
| CN (1) | CN100393715C (en) |
| AR (2) | AR041589A1 (en) |
| AT (5) | ATE500248T1 (en) |
| CY (2) | CY1108452T1 (en) |
| DE (4) | DE60336275D1 (en) |
| DK (2) | DK1908760T3 (en) |
| ES (5) | ES2309279T3 (en) |
| GB (2) | GB2393958A (en) |
| HK (1) | HK1116188A1 (en) |
| SI (2) | SI1408038T1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0708818D0 (en) * | 2007-05-08 | 2007-06-13 | Portela & Ca Sa | Compounds |
| WO2012087174A2 (en) * | 2010-12-22 | 2012-06-28 | BIAL - PORTELA & Cª., S.A. | Crystalline forms and processes for their preparation |
| GB201316410D0 (en) * | 2013-09-13 | 2013-10-30 | Bial Portela & Ca Sa | Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL82401A0 (en) * | 1986-05-06 | 1987-11-30 | Merrell Dow Pharma | Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them |
| US4868210A (en) | 1988-03-30 | 1989-09-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| MX9605145A (en) * | 1994-04-26 | 1997-12-31 | Syntex Inc | Benzocycloalkylazolethione derivatives. |
-
2002
- 2002-10-11 GB GB0223719A patent/GB2393958A/en not_active Withdrawn
- 2002-10-18 GB GB0224306A patent/GB2394223B/en not_active Expired - Lifetime
-
2003
- 2003-10-10 KR KR1020127005102A patent/KR101350741B1/en active IP Right Grant
- 2003-10-10 AT AT07076122T patent/ATE500248T1/en not_active IP Right Cessation
- 2003-10-10 SI SI200331309T patent/SI1408038T1/en unknown
- 2003-10-10 DK DK07076125.9T patent/DK1908760T3/en active
- 2003-10-10 DK DK03256420T patent/DK1408038T3/en active
- 2003-10-10 CN CNB2003801059426A patent/CN100393715C/en not_active Expired - Fee Related
- 2003-10-10 AT AT07076125T patent/ATE505465T1/en active
- 2003-10-10 ES ES03256420T patent/ES2309279T3/en not_active Expired - Lifetime
- 2003-10-10 DE DE60336275T patent/DE60336275D1/en not_active Expired - Lifetime
- 2003-10-10 ES ES07076122T patent/ES2361938T3/en not_active Expired - Lifetime
- 2003-10-10 DE DE60336276T patent/DE60336276D1/en not_active Expired - Lifetime
- 2003-10-10 ES ES07076124T patent/ES2361939T3/en not_active Expired - Lifetime
- 2003-10-10 DE DE60322642T patent/DE60322642D1/en not_active Expired - Lifetime
- 2003-10-10 DE DE60336772T patent/DE60336772D1/en not_active Expired - Lifetime
- 2003-10-10 ES ES07076125T patent/ES2364919T3/en not_active Expired - Lifetime
- 2003-10-10 AR ARP030103711A patent/AR041589A1/en active IP Right Grant
- 2003-10-10 AT AT03256420T patent/ATE403652T1/en active
- 2003-10-10 SI SI200331986T patent/SI1908760T1/en unknown
- 2003-10-10 AT AT07076123T patent/ATE550335T1/en active
- 2003-10-10 ES ES07076123T patent/ES2384118T3/en not_active Expired - Lifetime
- 2003-10-10 AT AT07076124T patent/ATE500247T1/en not_active IP Right Cessation
-
2008
- 2008-10-09 HK HK08111214.9A patent/HK1116188A1/en not_active IP Right Cessation
- 2008-10-24 CY CY20081101204T patent/CY1108452T1/en unknown
-
2011
- 2011-07-01 CY CY20111100639T patent/CY1112457T1/en unknown
-
2014
- 2014-03-18 AR ARP140101283A patent/AR095674A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2393958A (en) | 2004-04-14 |
| ATE550335T1 (en) | 2012-04-15 |
| ATE505465T1 (en) | 2011-04-15 |
| GB0224306D0 (en) | 2002-11-27 |
| CN1726211A (en) | 2006-01-25 |
| GB2394223B (en) | 2007-05-16 |
| DE60336276D1 (en) | 2011-04-14 |
| ES2309279T3 (en) | 2008-12-16 |
| GB2394223A (en) | 2004-04-21 |
| HK1116188A1 (en) | 2008-12-19 |
| ATE403652T1 (en) | 2008-08-15 |
| SI1908760T1 (en) | 2011-05-31 |
| ATE500247T1 (en) | 2011-03-15 |
| CY1108452T1 (en) | 2014-04-09 |
| KR101350741B1 (en) | 2014-01-10 |
| SI1408038T1 (en) | 2008-10-31 |
| AR041589A1 (en) | 2005-05-26 |
| CN100393715C (en) | 2008-06-11 |
| DE60336275D1 (en) | 2011-04-14 |
| CY1112457T1 (en) | 2015-12-09 |
| AR095674A2 (en) | 2015-11-04 |
| ATE500248T1 (en) | 2011-03-15 |
| DK1908760T3 (en) | 2011-07-25 |
| ES2361938T3 (en) | 2011-06-24 |
| DE60322642D1 (en) | 2008-09-18 |
| ES2364919T3 (en) | 2011-09-16 |
| GB0223719D0 (en) | 2002-11-20 |
| DE60336772D1 (en) | 2011-05-26 |
| ES2361939T3 (en) | 2011-06-24 |
| KR20120038014A (en) | 2012-04-20 |
| ES2384118T3 (en) | 2012-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC1482932I2 (en) | N3 alkylated benzimidazole derivatives as MEK inhibitors | |
| CY2016042I1 (en) | NEW HETEROCYCLIC COMPOUNDS ACTIVE AS BETA-LACTAMAS INHIBITORS | |
| NO20051236L (en) | Heterobiaryl derivatives as matrix metalloproteinase inhibitors | |
| NO20050426L (en) | Arylcarbonyl derivatives as therapeutic agents | |
| NO20050665L (en) | Pyrrolidone derivatives as MAOE inhibitors | |
| DK1478629T3 (en) | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterial agents | |
| DK1527050T3 (en) | Quinoline derivatives and their use as mycobacterial inhibitors | |
| DK1663232T3 (en) | Benzimidazole derivatives as human chymase inhibitors | |
| DK1789041T3 (en) | Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors | |
| IS7667A (en) | New benzimidazole derivatives | |
| DK1492785T3 (en) | 2-hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors | |
| DK1797042T3 (en) | Indozolone derivatives as 11B-HSD1 inhibitors | |
| DK1585749T3 (en) | Diazepinoindole derivatives as kinase inhibitors | |
| IS8384A (en) | Alkylated benzimidazole derivatives as MEK inhibitors | |
| ATE478870T1 (en) | SPIROINDOLINEPIPERIDEDINE DERIVATIVES | |
| ATE460418T1 (en) | HETEROCYCLOCARBOXAMIDE DERIVATIVES | |
| ATE450506T1 (en) | INDOLE-3-SULFUR DERIVATIVES | |
| ATE467631T1 (en) | QUINUCLIDINAMIDE DERIVATIVES | |
| IS7720A (en) | Piperidine-N-oxide derivatives | |
| DK2248807T3 (en) | N-phenyl-2-pyrimidineamine derivatives | |
| DK2305250T3 (en) | BENZIMIDAZOLD DERIVATIVES AND USE THEREOF AS PROTEINKINASE INHIBITORS | |
| NO20053569L (en) | Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists | |
| NO20043950L (en) | 3-cyclyl -5- (nitrogen-containing 5-membered ring) methyl oxazolidinone derivatives and their use as antibacterial agents | |
| ATE529428T1 (en) | THIOXANTHINE DERIVATIVES AS MYELOPEROXIDASINE INHIBITORS | |
| ATE386518T1 (en) | BENZIMIDAZOLE DERIVATIVES |